Pro Medicus Limited (OTCMKTS:PMCUF – Get Free Report)’s share price gapped down prior to trading on Wednesday . The stock had previously closed at $134.8044, but opened at $125.90. Pro Medicus shares last traded at $125.90, with a volume of 10 shares.
Wall Street Analysts Forecast Growth
Separately, Jefferies Financial Group downgraded shares of Pro Medicus from a “buy” rating to a “hold” rating in a research note on Wednesday, July 8th. One investment analyst has rated the stock with a Hold rating, According to MarketBeat, Pro Medicus presently has an average rating of “Hold” and a consensus target price of $155.00.
Check Out Our Latest Report on Pro Medicus
Pro Medicus Stock Performance
Pro Medicus Company Profile
Pro Medicus Limited is an Australia‐based healthcare technology company specializing in advanced medical imaging IT solutions. Its core offerings include radiology information systems (RIS), picture archiving and communication systems (PACS), and enterprise imaging platforms designed to streamline diagnostic workflows and enhance image management for healthcare providers.
The company’s flagship product suite, Visage 7, delivers high-performance visualization and reporting capabilities, enabling radiologists to access and manipulate large datasets with minimal latency.
See Also
- Five stocks we like better than Pro Medicus
- Could Truth API Become Trump Media’s First Meaningful Revenue Driver?
- Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying
- Moog Is More Than a Missile Maker, and Wall Street Is Noticing
- A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
Receive News & Ratings for Pro Medicus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro Medicus and related companies with MarketBeat.com's FREE daily email newsletter.
